Target intelligence / Profile preview

Novel transcript, antisense to KCNH3 (ENSG00000299006)

Target
ENSG00000299006
Molecular classification
Long noncoding RNA (lncRNA)
01

Overview

ENSG00000299006 encodes a long noncoding RNA, annotated as a novel transcript, antisense to KCNH3. It does not code for a protein and is not established as a functional gene product, therapeutic target, or biomarker. There is no evidence of involvement in disease or interaction with drugs. The biological significance of this transcript remains undefined, common for many annotated lncRNAs where experimental data are lacking. This entry is not a canonical drug target; it is a noncoding RNA transcript with currently limited biological and clinical annotation. Structured target information such as function, family, drug interactions, or disease role is formally "null".

02

Mechanism of action

None known

03

Biological functions

Unknown; no established function described. Most lncRNAs are involved in various regulatory processes, but no specific functional annotation is available for this transcript
04

Disease associations

None described; not associated with any disease

Beyond the preview

Go deeper on Novel transcript, antisense to KCNH3 (ENSG00000299006).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to KCNH3 (ENSG00000299006).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call